Cornelia Haag-Molkenteller
Chief Tech/Sci/R&D Officer at UROVANT SCIENCES LTD.
Profile
Cornelia Haag-Molkenteller is currently the Chief Medical Officer at Urovant Sciences, Inc. and the Chief Medical Officer & Executive Vice President at Urovant Sciences Ltd.
Prior to her current positions, she worked at Allergan Ltd.
(Ireland) as Vice President-Clinical Development from 2015 to 2018 and at Schwarz BioSciences GmbH as Vice President-Clinical Program from 1988 to 2006.
She holds a doctorate degree from Johann Wolfgang Goethe-Universität Frankfurt am Main.
Cornelia Haag-Molkenteller active positions
Companies | Position | Start |
---|---|---|
UROVANT SCIENCES LTD. | Chief Tech/Sci/R&D Officer | 2018-03-31 |
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The private company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Chief Tech/Sci/R&D Officer | 2018-03-31 |
Former positions of Cornelia Haag-Molkenteller
Companies | Position | End |
---|---|---|
ALLERGAN PLC | Corporate Officer/Principal | 2018-02-28 |
Schwarz BioSciences GmbH | Corporate Officer/Principal | 2005-12-31 |
Training of Cornelia Haag-Molkenteller
Johann Wolfgang Goethe-Universität Frankfurt am Main | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
Allergan Ltd. (Ireland)
Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
Schwarz BioSciences GmbH | |
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The private company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Health Technology |
Urovant Sciences Ltd.
Urovant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Urovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which through its subsidiaries, engages in the development and commercialization of therapies for urologic conditions. Its pipeline includes Vibegron (RVT-901) and URO-902. The company was founded on January 27, 2016 and is headquartered in London, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Cornelia Haag-Molkenteller